Have Bank Regulators Effectively Responded to the Financial Crisis?
External committee offers recommendations to enhance OCC supervision of financial institutions.
Cost and Benefit Changes During Federal Rulemakings
Data from recent rulemakings do not show that OIRA review systematically lowers estimated benefits and increases estimated costs.
My Pathway
Robert A. Kagan provides his own perspective on major influences and broad themes underpinning his research.
Robert A. Kagan: Scholar of Professional Expertise
Kagan’s agenda favors professionalism as the key alternative to hyper-adversarial contestation.
Kagan the Comparativist
Robert A. Kagan’s comparative perspective on American law and politics has set the stage for a productive debate over regulation.
Robert A. Kagan: Man of Style
Kagan’s insight on legal “styles” paves the way for future regulatory studies and policymaking efforts.
Kagan the Explorer
Robert A. Kagan’s research is a quest to understand legal authority and how it works in the world.
Honoring Robert A. Kagan
In a five-part series, The Regulatory Review explores and honors the contributions of political scientist Robert A. Kagan.
Supreme Court Confronts Interstate Air Pollution Regulation
The Court hears oral arguments on legal challenge to EPA rule requiring states to keep pollution from affecting their neighbors.
FDA to Require Medical Device ID Numbers
New agency rule designed to help identify faulty medical devices.
Learning from the FDA’s Plan B Fiasco
Plan B episode calls for reconsidering the scope of judicial review and the role of politics in rulemaking.
Moving Toward the Evaluation State
By taking three feasible steps, the administration could help build a regulatory culture more supportive of ex post evaluation.